Status:
ACTIVE_NOT_RECRUITING
Intravoxel Incoherent Motion (IVIM) Magnetic Resonance Imaging in Multiple Sclerosis
Lead Sponsor:
Chinese University of Hong Kong
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Intravoxel incoherent motion (IVIM) is technique based on diffusion-weighted imaging (DWI). In this study, the investigators evaluate the use of IVIM in patients with Multiple Sclerosis.
Detailed Description
Intravoxel incoherent motion (IVIM) is technique based on diffusion-weighted imaging (DWI), it is achieved through an MRI acquisition with multiple small b value to extract perfusion data. It has been...
Eligibility Criteria
Inclusion
- Patients who are 18 years or older.
- Relapsing-remitting MS diagnosed as per Macdonald criteria
Exclusion
- Contraindication to MRI. For example, metal implantation in the body, claustrophobia and pregnancy.
- Patients who are unable to tolerate the scans without moving the head as a result of symptoms such as tremor, spasticity, involuntary movements and spasms, cognitive impairment, coughing, and shortness of breath.
Key Trial Info
Start Date :
January 30 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05391906
Start Date
January 30 2023
End Date
December 30 2026
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CUHK
Hong Kong, Hong Kong